Supplemental Optoacoustic Imaging of Breast Masses: A Cost-Effectiveness Analysis

OA/US is more cost-effective than US to differentiate benign or malignant breast masses in the diagnostic setting. It can reduce costs while improving patients' quality of life, primarily by reducing false-positive results with consequent benign biopsies.